AXIO BIOSOLUTIONS
Axio is a medtech R&D and Manufacturing Company focused on Advanced Surgical and wound care. Axio has the distinction to be the first company from India to get USFDA clearance for a woundcare/hemostat product. Controlling life threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce the mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardio-vascular and Dental applications.
AXIO BIOSOLUTIONS
Industry:
Emergency Medicine Health Care Manufacturing Medical Medical Device
Founded:
2008-05-16
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.axiobio.com
Total Employee:
101+
Status:
Active
Contact:
+91 8860786067
Email Addresses:
[email protected]
Total Funding:
21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Singular Medical
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management products.
Current Advisors List
Current Employees Featured
Founder
Investors List
Accel India
Accel India investment in Series B - Axio Biosolutions
UC-RNT Fund
UC-RNT Fund investment in Series B - Axio Biosolutions
TrueScale Capital
TrueScale Capital investment in Series B - Axio Biosolutions
Omidyar Network India
Omidyar Network India investment in Series B - Axio Biosolutions
Omidyar Network
Omidyar Network investment in Series B - Axio Biosolutions
Accel India
Accel India investment in Series B - Axio Biosolutions
RNT Capital
RNT Capital investment in Series B - Axio Biosolutions
Chiratae Ventures
Chiratae Ventures investment in Series B - Axio Biosolutions
Chiratae Ventures
Chiratae Ventures investment in Series B - Axio Biosolutions
RNT Capital
RNT Capital investment in Series B - Axio Biosolutions
Official Site Inspections
http://www.axiobio.com Semrush global rank: 2.88 M Semrush visits lastest month: 5.62 K
- Host name: 62.72.28.200
- IP address: 62.72.28.200
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
